Active Biotech AB

Research and Markets: Competitor Analysis: FGF-R Agonists and Antagonist - A Compilation of Current Active Projects in Research and Development of Molecules Targeting FGF.
Business Wire; 11/5/2009; 1198 words; ...platelets. The report includes a compilation of current active projects in research and development of molecules...PDGF-R Agonist and Antagonist R&D Pipelines: * AB Science * Accelera * ACT Biotech * Advenchen Laboratories * Ambrx * Amgen * Ariad...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1851 words; Active Biotech AB, of Lund, Sweden, selected a candidate drug, ABR-215757, within the systemic lupus erythematosus project (SLE) for clinical...

Perrigo Announces Dismissal of Duac Patent Litigation.
Biotech Week; 11/4/2009; 860 words; ...affordable." This product is the AB-rated equivalent to Stiefel...pharmaceuticals, nutritional products, active pharmaceutical ingredients...This article was prepared by Biotech Week editors from staff and other reports. Copyright 2009, Biotech Week via NewsRx.com.

Perrigo Announces Dismissal of Duac[R] Patent Litigation.
Biotech Week; 11/4/2009; 741 words; ...affordable." This product is the AB-rated equivalent to Stiefel...pharmaceuticals, nutritional products, active pharmaceutical ingredients...This article was prepared by Biotech Week editors from staff and other reports. Copyright 2009, Biotech Week via NewsRx.com.

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 1236 words; o Active Biotech AB, of Lund, Sweden, reported data from an interim analysis of the...treatment. The trial is expected to involve a total of 24 patients. Active Biotech anticipates starting Phase II/III studies next year. o Avidia Inc...